Nienke Beerlage-de Jong1, Jobke Wentzel2, Ron Hendrix3, Lisette van Gemert-Pijnen4. 1. Psychology, Health, and Technology, University of Twente, Enschede, The Netherlands. Electronic address: n.beerlage-dejong@utwente.nl. 2. Psychology, Health, and Technology, University of Twente, Enschede, The Netherlands; Department of Media, Communication, and Organisation, University of Twente, Enschede, The Netherlands. 3. Clinical Bacteriology Unit, Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Certe Laboratory for Infectious Diseases, Groningen, The Netherlands. 4. Psychology, Health, and Technology, University of Twente, Enschede, The Netherlands.
Abstract
BACKGROUND: Current clinical decision support systems (CDSSs) for antimicrobial stewardship programs (ASPs) are guideline- or expert-driven. They are focused on (clinical) content, not on supporting real-time workflow. Thus, CDSSs fail to optimally support prudent antimicrobial prescribing in daily practice. Our aim was to demonstrate why and how participatory development (involving end-users and other stakeholders) can contribute to the success of CDSSs in ASPs. METHODS: A mixed-methods approach was applied, combining scenario-based prototype evaluations (to support verbalization of work processes and out-of-the-box thinking) among 6 medical resident physicians with an online questionnaire (to cross-reference findings of the prototype evaluations) among 54 Dutch physicians. RESULTS: The prototype evaluations resulted in insight into the end-users and their way of working, as well as their needs and expectations. The online questionnaire that was distributed among a larger group of medical specialists, including lung and infection experts, complemented the findings of the prototype evaluations. It revealed a say/do problem concerning the unrecognized need of support for selecting diagnostic tests. CONCLUSIONS: Low-fidelity prototypes of a technology allow researchers to get to know the end-users, their way of working, and their work context. Involving experts allows technology developers to continuously check the fit between technology and clinical practice. The combination enables the participatory development of technology to successfully support ASPs.
BACKGROUND: Current clinical decision support systems (CDSSs) for antimicrobial stewardship programs (ASPs) are guideline- or expert-driven. They are focused on (clinical) content, not on supporting real-time workflow. Thus, CDSSs fail to optimally support prudent antimicrobial prescribing in daily practice. Our aim was to demonstrate why and how participatory development (involving end-users and other stakeholders) can contribute to the success of CDSSs in ASPs. METHODS: A mixed-methods approach was applied, combining scenario-based prototype evaluations (to support verbalization of work processes and out-of-the-box thinking) among 6 medical resident physicians with an online questionnaire (to cross-reference findings of the prototype evaluations) among 54 Dutch physicians. RESULTS: The prototype evaluations resulted in insight into the end-users and their way of working, as well as their needs and expectations. The online questionnaire that was distributed among a larger group of medical specialists, including lung and infection experts, complemented the findings of the prototype evaluations. It revealed a say/do problem concerning the unrecognized need of support for selecting diagnostic tests. CONCLUSIONS: Low-fidelity prototypes of a technology allow researchers to get to know the end-users, their way of working, and their work context. Involving experts allows technology developers to continuously check the fit between technology and clinical practice. The combination enables the participatory development of technology to successfully support ASPs.
Authors: Hanneke Kip; Saskia M Kelders; Yvonne H A Bouman; Lisette J E W C van Gemert-Pijnen Journal: J Med Internet Res Date: 2019-08-19 Impact factor: 5.428
Authors: Po-Yin Yen; Randi E Foraker; Jacob K Greenberg; Ayodamola Otun; Azzah Nasraddin; Ross C Brownson; Nathan Kuppermann; David D Limbrick Journal: BMC Med Inform Decis Mak Date: 2021-05-19 Impact factor: 2.796
Authors: Hanneke Kip; Julia Keizer; Marcia C da Silva; Nienke Beerlage-de Jong; Nadine Köhle; Saskia M Kelders Journal: J Med Internet Res Date: 2022-01-27 Impact factor: 5.428
Authors: Hanneke Kip; Yvonne H A Bouman; Saskia M Kelders; Lisette J E W C van Gemert-Pijnen Journal: Front Psychiatry Date: 2018-02-21 Impact factor: 4.157